INSM

2024Q3BMO

Insmed Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2024-10-31 · Fiscal end 2024-09-30 · Features as of 2024-10-30

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-1.22
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.9%
IV front—
P/C full—
P/C front—
Features as of2024-10-30

Run-up

Close—
Ret 5d-2.3%
Ret 10d-8.3%
Ret 20d-3.7%
Ret 30d-3.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-1.27Miss
Estimated EPS-1.22
Actual revenue
93.4M
Surprise %-4.1%
Beat / missMiss
Beat streak 40
Beat streak 80

Reaction

1-day stock reaction-1.9%
Implied vs actual

Implied 2.9%Actual 2.4%

Gap reaction-2.4%
Day result-4.3%
Next-day upNo
Realized / IV0.83×

Post tape

Post 5d+6.6%
Post 10d+5.9%
Post volume2.4M
Vol ×10d2.42×
Vol ×20d2.36×
Post range4.9%